Effects of the noradrenergic neurotoxin DSP-4 on the expression of α1-adrenoceptor subtypes after antidepressant treatment
G Kreiner, A Zelek-Molik, M Kowalska… - Pharmacological …, 2011 - Springer
We have previously reported that chronic imipramine and electroconvulsive treatments
increase the α 1A-adrenoceptor (but not the α 1B subtype) mRNAlevel and the receptor …
increase the α 1A-adrenoceptor (but not the α 1B subtype) mRNAlevel and the receptor …
Effects of the noradrenergic neurotoxin DSP-4 on the expression of α1-adrenoceptor subtypes after antidepressant treatment
G Kreiner, A Zelek-Molik… - Pharmacological …, 2011 - pubmed.ncbi.nlm.nih.gov
We have previously reported that chronic imipramine and electroconvulsive treatments
increase the α (1A)-adrenoceptor (but not the α (1B) subtype) mRNA level and the receptor …
increase the α (1A)-adrenoceptor (but not the α (1B) subtype) mRNA level and the receptor …
[PDF][PDF] Effects of the noradrenergic neurotoxin DSP-4 on the expression of α1-adrenoceptor subtypes after antidepressant treatment
G Kreiner, A Zelek-Molik, M Kowalska… - Pharmacological …, 2011 - Citeseer
We have previously reported that chronic imipramine and electroconvulsive treatments
increase the α1A-adrenoceptor (but not the α1B subtype) mRNA level and the receptor …
increase the α1A-adrenoceptor (but not the α1B subtype) mRNA level and the receptor …
Effects of the noradrenergic neurotoxin DSP-4 on the expression of α1-adrenoceptor subtypes after antidepressant treatment
G Kreiner, A Zelek-Molik, M Kowalska… - Pharmacological …, 2011 - Elsevier
We have previously reported that chronic imipramine and electroconvulsive treatments
increase the α 1A-adrenoceptor (but not the α 1B subtype) mRNA level and the receptor …
increase the α 1A-adrenoceptor (but not the α 1B subtype) mRNA level and the receptor …
Effects of the noradrenergic neurotoxin DSP-4 on the expression of α1-adrenoceptor subtypes after antidepressant treatment.
G Kreiner, A Zelek-Molik, M Kowalska… - Pharmacological …, 2011 - europepmc.org
We have previously reported that chronic imipramine and electroconvulsive treatments
increase the α (1A)-adrenoceptor (but not the α (1B) subtype) mRNA level and the receptor …
increase the α (1A)-adrenoceptor (but not the α (1B) subtype) mRNA level and the receptor …
[PDF][PDF] Effects of the noradrenergic neurotoxin DSP-4 on the expression of α1-adrenoceptor subtypes after antidepressant treatment
G Kreiner, A Zelek-Molik, M Kowalska… - Pharmacological …, 2011 - if-pan.krakow.pl
We have previously reported that chronic imipramine and electroconvulsive treatments
increase the α1A-adrenoceptor (but not the α1B subtype) mRNA level and the receptor …
increase the α1A-adrenoceptor (but not the α1B subtype) mRNA level and the receptor …
[PDF][PDF] Effects of the noradrenergic neurotoxin DSP-4 on the expression of α1-adrenoceptor subtypes after antidepressant treatment
G Kreiner, A Zelek-Molik, M Kowalska… - Pharmacological …, 2011 - academia.edu
We have previously reported that chronic imipramine and electroconvulsive treatments
increase the α1A-adrenoceptor (but not the α1B subtype) mRNA level and the receptor …
increase the α1A-adrenoceptor (but not the α1B subtype) mRNA level and the receptor …
Effects of the noradrenergic neurotoxin DSP-4 on the expression of α1-adrenoceptor subtypes after antidepressant treatment
G Kreiner, A Zelek-Molik, M Kowalska… - Pharmacological …, 2011 - if-pan.krakow.pl
We have previously reported that chronic imipramine and electroconvulsive treatments
increase the α)-adrenoceptor (but not the α* subtype) mRNA level and the receptor density …
increase the α)-adrenoceptor (but not the α* subtype) mRNA level and the receptor density …